Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma

European Journal of Haematology

Volumn 70, Issue 4, 2003, Pages 225-230

  Rapezzi, Davide ^a   Sticchi, Laura ^b   Racchi, Omar ^a   Mangerini, Rosa ^a   Ferraris, Anna Maria ^a   Gaetani, Gian Franco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Influenza; Lymphoproliferative disorders; Myeloma; Vaccine

Indexed keywords

IMMUNOGLOBULIN; INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; EPIDEMIC; FEMALE; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; SEROCONVERSION; SIDE EFFECT; VIRUS ISOLATION; VIRUS STRAIN;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOGLOBULINS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; SAFETY; SEASONS; VACCINATION;

EID: 0344837707     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00028.x     Document Type: Article

References (28)

1. JACOBSON DR, ZOLLA-PAZNER S. Immunosuppression in multiple myeloma. Semin Oncol 1986;13:282-290.
2. MORRISON VA. The infectious complications of chronic lymphocytic leukemia. Semin Oncol 1998;25:98-106.
3. BRODER S,HUMPHREY R, DURM M, BLACKMAN M, MEADE B, GOLDMAN C, STROBER W, WALDMANN T. Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma. Role of suppressor cells. N Engl J Med 1975;293:887-892.
4. BARTIK MM, WELKER D, KAY NE. Impairments in immune cell function in B cell chronic lymphocytic leukemia. Semin Oncol 1998;25:27-33.
5. TSIODRAS S, SAMONIS G, KEATING MJ, KONTOYIANNIS DP. Infection and immunity in chronic lymphocytic leukemia. Mayo Clin Proc 2000;75:1039-1054.
6. GRIBABIS DA, PANAYOTIDIS P, BOUSSIOTIS VA, HANNOUN C, PANGALIS GA. Influenza virus vaccine in B-cell chronic lymphocytic leukemia patients. Acta Haematol 1994;9:115-118.
7. BRYDAK LB, CALBECKA M. Immunogenicity of influenza vaccine in patients with hemato-oncological disorders. Leuk Lymphoma 1999;32:369-374
8. ROBERTSON JD, NAGESH K, JOWITT SN, DOUGLAS M, ANDERSON H, MUTTON K, ZAMBON M, SCARFFE JH. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae, and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 2000;82:219-220.
9. SCHAFER AI, CHURCHILL WH, AMES P. WEINSTEIN L. The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine. Cancer 1979;43:25-30.
10. BUCALOSSI A, MAROTTA G, GALIENI P, BIGAZZI C, VALENZIN PE, DISPENSA E. Immunological response to influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol 1995;93:56.
11. GROSS PA, HERMOGENES AW, SACKS HS, LAU J, LEVANDOWSKI RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518-527.
12. HIROTA Y, KAJI M, IDE S, GOTO S, OKA T. The hemag-glutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: with special reference to the prevaccination antibody and its interaction with age. Vaccine 1996;14:1597-1602.
13. KEITEL WA, CATE TR, COUCH RB, HUGGINS LL, HESS KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997;15:1114-1422.
14. DE BRUIJN IA, REMARQUE EJ, BEYER WE, LE CESSIE S, MASUREL N, LIGTHART GJ. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine 1997;15:1323-1329.
15. BEYER WE, DE BRUIJN IA, PALACHE AM, WESTENDORP RG, OSTERHAUS AD. Protection against influenza after annually repeated vaccination: a meta-analysis of serological and field studies. Arch Intern Med 1999;159:182-188.
16. GLUCK R, MISCHLER R, FINKEL B, QUE JU, SCARPE B, CRYZ SJ. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet 1994;344:160-163.
17. WHO. Recommended composition of influenza virus vaccines for use in the 1999-2000 season. Wkly Epidemiol Rec 1999;74:57-61.
18. SCHAAD UB, BÜHLMANN U, BURGER R, RUEDERBERG A, WILDER-SMITH A, RUTISHAUSER M, SENNHAUSER F, HERZOG C, ZELLMEYER M, GLUCK R. Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis. Antimicrob Agents Chemother 2000;44:1163-1167.
19. POTTER CW, OXFORD JS. Determinants of immunity to influenza infection in man. Br Med Bull 1979;35:69-75.
20. European Agency for the Evaluation of Medicinal Products (EMEA). Ad hoc working party on influenza vaccines: summary record of meeting on the choice of strains for influenza vaccine for the 1995-1996 vaccination campaign. Brussels, 27 February 1995.
21. nd edn. Chicester: John Wiley & Sons, 1993.
22. GANZ PA, SHANLEY JD, CHERRY JD. Response of patients with neoplastic diseases to influenza virus vaccine. Cancer 1978;42:2244-2247.
23. ANDERSON H, PETRIE K, BERRISFORD C, CHARLETT A, THATCHER N, ZAMBON M. Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer 1999;80:219-220.
24. CHISHOLM JC, DEVINE T, CHARLETT A, PINKERTON CR, ZAMBON M. Response to influenza immunisation during treatment for cancer. Arch Dis Child 2001;84:496-500.
25. NICHOL KL, BAKEN L, NELSON A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999;130:397-403
26. COUCH RB. Prevention and treatment of influenza. N Engl J Med 2000;343:1778-1787.
27. PALACHE AM, BEYER WE, SPRENGER MJ, MASUREL N, DE JONGE S, VARDY A, CHARPENTIER B, NOURY J, VAN BEEK WC, BORST RJ. Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers. Vaccine 1993;11:3-9.
28. PALACHE AM, BEYER WE, LUCHTERS G, VOLKER R, SPRENGER MJ, MASUREL N. Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature. Vaccine 1993;11:892-908.